AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology

San Diego Biotechnology Network
San Diego Biotechnology Network
AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology
Loading
/

SAN DIEGO–(BUSINESS WIRE)–AvantGen Announces Strategic Collaboration to Develop NK Cell Engager Technology